Propanc Biopharma Inc (PPCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -785 | -354 | -1,821 | -1,462 | -935 |
| Accounts payable and accrued liabilities | 102 | -19 | 242 | 243 | 169 |
| Other Working Capital | 330 | 69 | 417 | 522 | 185 |
| Other Operating Activity | 136 | 69 | 225 | 22 | 9 |
| Operating Cash Flow | $-217 | $-236 | $-935 | $-675 | $-572 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 394 | 156 | 982 | 823 | 767 |
| Debt Issued | N/A | N/A | 80 | N/A | N/A |
| Common Stock Issued | N/A | N/A | 23 | 11 | N/A |
| Other Financing Activity | -123 | 60 | -143 | -143 | -143 |
| Financing Cash Flow | $271 | $216 | $942 | $691 | $624 |
| Exchange Rate Effect | -60 | 8 | 4 | -20 | 10 |
| Beginning Cash Position | 21 | 21 | 10 | 10 | 10 |
| End Cash Position | 15 | 9 | 21 | 6 | 72 |
| Net Cash Flow | $-7 | $-12 | $11 | $-4 | $62 |
| Free Cash Flow | |||||
| Operating Cash Flow | -217 | -236 | -935 | -675 | -572 |
| Free Cash Flow | -217 | -236 | -935 | -675 | -572 |